Alcon: Hypertension trials

The registry lists 104 Hypertension studies with Alcon as lead sponsor. 0 are open to participants now and 45 have results posted.

Phase 1 2Phase 2 28Phase 3 47Phase 4 26No phase 3(a study in two phases counts in both)

Studies

Page 2 of 2. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Study of TRAVATAN in Subjects With Iris Pigmentation ChangesTerminatedNCT00047554
• Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-70CompletedNCT00047541Phase 3
• Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-02-41CompletedNCT00047528Phase 3
• Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-69CompletedNCT00047515Phase 3